Intrust Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Sell
6,518
-424
-6% -$28.9K 0.04% 268
2026
Q1
$449K Buy
6,942
+317
+5% +$22.3K 0.04% 278
2025
Q4
$446K Buy
6,625
+60
+0.9% +$4.04K 0.04% 272
2025
Q3
$481K Buy
6,565
+1,959
+43% +$130K 0.04% 266
2025
Q2
$240K Buy
4,606
+625
+16% +$35.6K 0.02% 373
2025
Q1
$254K Buy
+3,981
New +$231K 0.03% 343

Other funds holding HALO

Intrust Bank's HALO Position: Q2 2026 in Review

Intrust Bank reduced its Halozyme (HALO) stake by 6.1% in Q2 2026, selling an estimated $28.9K and leaving 6,518 shares worth $510K. The position accounts for 0.04% of the portfolio, ranked #268.

Intrust Bank first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Intrust Bank held 6,518 shares of Halozyme worth $510K as of Q2 2026.
  • Intrust Bank sold 424 Halozyme shares in Q2 2026, an estimated $28.9K.
  • Halozyme made up 0.04% of Intrust Bank's portfolio in Q2 2026, its #268 holding.
  • Intrust Bank first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.